| Document Type
|
:
|
BL
|
| Record Number
|
:
|
857823
|
| Main Entry
|
:
|
Mwebe, Herbert
|
| Title & Author
|
:
|
Psychopharmacology : : a mental health professionals guide to commonly used medications /\ Herbert Mwebe.
|
| Publication Statement
|
:
|
St Albans :: Critical Publishing,, [2018]
|
|
|
:
|
, ©2018
|
| Series Statement
|
:
|
Nursing
|
| Page. NO
|
:
|
1 online resource
|
| ISBN
|
:
|
1912096013
|
|
|
:
|
: 1912096021
|
|
|
:
|
: 191209603X
|
|
|
:
|
: 9781912096015
|
|
|
:
|
: 9781912096022
|
|
|
:
|
: 9781912096039
|
|
|
:
|
1912096048
|
|
|
:
|
9781912096046
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and index.
|
| Contents
|
:
|
Cover; Title page; Copyright information; Table of contents; Meet the author; Acknowledgments; Foreword; What the reviewers say; Introduction; The structure of this book; Learning features; 1 Mental illness; 1.1 Introduction; 1.2 Aetiology of mental illness; 1.3 Neurodevelopmental theories; Neurons and neurotransmitters; 1.4 Clinical decision-making in practice and medicine management; 2 Drugs used in psychoses; 2.1 Introduction; 2.2 Mechanism of action; Biochemical theories; Glutamate hypothesis; Dopamine hypothesis; Typical antipsychotics (first-generation antipsychotics)
|
|
|
:
|
3.3 Dose and administration3.4 Adverse effects and management; Tricyclic antidepressants; Adverse effects and management; Selective serotonin reuptake inhibitors; Adverse effects and management; Serotonin-noradrenaline reuptake inhibitors; Adverse effects and management; Examples of discontinuation symptoms; Tetracyclic (noradrenergic and specific serotonergic antidepressants); Adverse effects and management; Aminoketone (bupropion); Adverse effects and management; Monoamine oxidase inhibitors; Precautions, side effects and management; Reversible inhibitor of monoamine oxidase type A
|
|
|
:
|
Atypical antipsychotics (second-generation antipsychotics)2.3 Dose and administration; Rapid tranquillisation; Antipsychotic drugs in depot preparation; Prescribing antipsychotic drugs to smokers; 2.4 Adverse effects and management; Extrapyramidal side effects; Dystonia; Management of dystonia; Akathisia; Management of akathisia; Drug-induced parkinsonism; Management of drug-induced parkinsonism; Tardive dyskinesia; Management of tardive dyskinesia; Anticholinergic drugs; Non-extrapyramidal adverse effects of antipsychotic drugs; Muscarinic 1 receptor block; Cardiovascular effects
|
|
|
:
|
Side effectsSerotonin syndrome; 3.5 Differences in therapeutic effects of antidepressants; 4 Drugs used in dementia; 4.1 Introduction; 4.2 Mechanism of action; Acetylcholinesterase inhibitors; 4.3 Dose and administration; 4.4 Adverse effects and management; Acetylcholinesterase inhibitors; Polypharmacy in the older person; Antipsychotic therapy in the care of the older person; 4.5 Memantine (NMDA receptor antagonist); Mechanism of action of memantine; Concomitant use of cholinesterase inhibitors and memantine; Adverse effects and management of memantine; 5 Drugs used in bipolar disorders
|
|
|
:
|
Weight gain and mental illnessGender; Socioeconomic status and level of education; Age; Other contributing factors to weight gain in people with mental illness; Weight gain monitoring and management; Endocrine adverse effects; Allergic and dermatological effects; Haematological adverse effects; Obligatory monitoring for clozapine therapy; Clozapine alert; Other adverse effects of clozapine; Neuroleptic malignant syndrome; 2.5 Medication adherence in mental health settings; 3 Drugs used in depression; 3.1 Introduction; 3.2 Mechanism of action; Monoamine theory of depression
|
| Abstract
|
:
|
An essential text for all trainee and registered health professionals who require knowledge and understanding of drugs used in the treatment of mental health conditions for prescribing or administering purposes.
|
| Subject
|
:
|
Psychopharmacology.
|
| Subject
|
:
|
Psychotropic drugs.
|
| Subject
|
:
|
MEDICAL-- Pharmacology.
|
| Subject
|
:
|
Psychopharmacology.
|
| Subject
|
:
|
Psychotropic drugs.
|
| Subject
|
:
|
Psychotropic Drugs-- pharmacology.
|
| Subject
|
:
|
Psychopharmacology.
|
| Dewey Classification
|
:
|
615.78
|
| LC Classification
|
:
|
RM315
|
| NLM classification
|
:
|
2018 I-384
|
|
|
:
|
QV 77.2
|